Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.73% |
| 2 | Technology | 20.55% |
| 3 | Financials | 7.82% |
| 4 | Consumer Discretionary | 7.64% |
| 5 | Communication Services | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5301
DELISTED
Ontrak
OTRK
| $174 | ﹤0.01% |
+348
| New | +$505 |
2025 Q2
0 quarters
|
|
5302
DELISTED
Zynex
ZYXI
| $173 | ﹤0.01% |
67
-10,800
| -99% | -$24.4K |
2019 Q1
25 quarters
|
|
5303
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.3B
| $163 | ﹤0.01% |
3
-27
| -90% | -$1.39K |
2022 Q1
13 quarters
|
|
5304
First Trust Technology AlphaDEX Fund
FXL
$2.82B
| $157 | ﹤0.01% |
+1
| New | +$142 |
2025 Q2
0 quarters
|
|
5305
Baozun
BZUN
$213M
| $153 | ﹤0.01% |
61
| – | – |
2015 Q4
38 quarters
|
|
5306
Seer Inc
SEER
$113M
| $152 | ﹤0.01% |
71
-38,999
| -100% | -$78.1K |
2020 Q4
18 quarters
|
|
5307
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $151 | ﹤0.01% |
+6
| New | +$151 |
2025 Q2
0 quarters
|
|
5308
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.51B
| $138 | ﹤0.01% |
+1
| New | +$134 |
2025 Q2
0 quarters
|
|
5309
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.05B
| $137 | ﹤0.01% |
+2
| New | +$128 |
2025 Q2
0 quarters
|
|
5310
DELISTED
ACTELIS NETWORKS INC
ASNS
| $135 | ﹤0.01% |
+22
| New | +$151 |
2025 Q2
0 quarters
|
|
5311
Nexentis Technologies
NXTS
$991K
| $134 | ﹤0.01% |
+2
| New | +$134 |
2025 Q2
0 quarters
|
|
|
CANG
5312
Cango Inc
CANG
$156M
| $131 | ﹤0.01% |
3
| – | – |
2021 Q1
17 quarters
|
|
5313
John Hancock Multifactor Mid Cap ETF
JHMM
$5.96B
| $122 | ﹤0.01% |
2
-37
| -95% | -$2.13K |
2025 Q1
1 quarter
|
|
5314
NovaBridge Biosciences American Depositary Shares
NBP
$149M
| $121 | ﹤0.01% |
50
| – | – |
2020 Q4
18 quarters
|
|
5315
Artelo Biosciences
ARTL
$1.5M
| – | – |
0
| – | – |
2025 Q2
0 quarters
|
|
5316
Next Technology
NXTT
$7.7M
| – | – |
0
| – | – |
2025 Q2
0 quarters
|
|
5317
Adams Diversified Equity Fund
ADX
$3.22B
| $109 | ﹤0.01% |
5
| – | – |
2013 Q2
48 quarters
|
|
5318
Invesco Taxable Municipal Bond ETF
BAB
$858M
| $106 | ﹤0.01% |
+4
| New | +$105 |
2025 Q2
0 quarters
|
|
5319
Century Casinos
CNTY
$22.4M
| $106 | ﹤0.01% |
50
-187
| -79% | -$334 |
2023 Q2
8 quarters
|
|
5320
FibroBiologics
FBLG
$7.08M
| $106 | ﹤0.01% |
9
-965
| -99% | -$17.4K |
2024 Q1
5 quarters
|
|
5321
Emerson Radio
MSN
$7.39M
| $104 | ﹤0.01% |
+305
| New | +$124 |
2025 Q2
0 quarters
|
|
5322
Kiora Pharmaceuticals
KPRX
$10.7M
| $101 | ﹤0.01% |
+35
| New | +$107 |
2025 Q2
0 quarters
|
|
5323
Seres Therapeutics
MCRB
$25.4M
| $100 | ﹤0.01% |
9
-2
| -18% | -$18 |
2015 Q3
39 quarters
|
|
5324
iShares US Infrastructure ETF
IFRA
$3.98B
| $98 | ﹤0.01% |
+2
| New | +$93 |
2025 Q2
0 quarters
|
|
5325
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.08B
| $97 | ﹤0.01% |
+4
| New | +$97 |
2025 Q2
0 quarters
|
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2025 filing shows 467 new, 1,653 increased, 2,974 reduced and 377 closed positions. Its largest new stake was Amrize Ltd: 2,294,135 shares worth $114M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $625M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 467 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.